We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Low Bone Mass in Premenopausal or Perimenopausal Women

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00005101
First Posted: April 7, 2000
Last Update Posted: June 24, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Columbia University
Information provided by:
National Center for Research Resources (NCRR)
April 6, 2000
April 7, 2000
June 24, 2005
February 1998
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Low Bone Mass in Premenopausal or Perimenopausal Women
Not Provided

OBJECTIVES:

I. Determine the possible causes of bone loss in premenopausal or perimenopausal women.

PROTOCOL OUTLINE: Patients undergo physical examination and complete history with emphasis on risk factors for osteoporosis and screening for occult secondary causes of osteoporosis through blood serum and 24 hour urine collection.

Patients with more than 6 months since prior bone mineral density measurements or who did not receive measurements at participating center, undergo dual energy x-ray absorptiometry over 30 minutes for bone mineral density measurements.

Observational
Primary Purpose: Screening
Not Provided
Not Provided
Not Provided
Not Provided
Osteoporosis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics--

  • Low bone mass (T score less than -2.0) with no secondary cause on routine exam
  • Premenopausal

OR

  • Perimenopausal

--Prior/Concurrent Therapy--

  • Chemotherapy: No prior or concurrent chemotherapeutic agents
  • Endocrine therapy: No prior or concurrent glucocorticoids or suppressive doses of thyroid hormone
  • Other: No prior or concurrent anticonvulsants

--Patient Characteristics--

  • Hematopoietic: No multiple myeloma
  • Other: No hyperparathyroidism No thyrotoxicosis No anorexia nervosa No Paget's disease of bone No rheumatoid arthritis No Cushing's syndrome No malabsorption syndrome No type I diabetes mellitus
Sexes Eligible for Study: Female
16 Years to 54 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00005101
NCRR-M01RR00645-2738
CPMC-IRB-8414
CPMC-GCRC-2738
Not Provided
Not Provided
Not Provided
Not Provided
National Center for Research Resources (NCRR)
Columbia University
Study Chair: Elizabeth Shane Columbia University
National Center for Research Resources (NCRR)
December 2003